California Public Employees Retirement System Alkermes Plc. Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

A detailed history of California Public Employees Retirement System transactions in Alkermes Plc. stock. As of the latest transaction made, California Public Employees Retirement System holds 323,548 shares of ALKS stock, worth $9.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

323,548

Previous 315,761 2.47%

Holding current value

$9.38 Million

Previous $8.55 Million 8.78%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $180,736 - $212,117	7,787 Added 2.47%	323,548 $7.8 Million
Q1 2024 Apr 30, 2024	SELL	$26.4 - $32.56 $17.1 Million - $21.1 Million	-649,431 Reduced 67.29%	315,761 $8.55 Million
Q4 2023 Feb 01, 2024	SELL	$23.37 - $28.68 $61,042 - $74,912	-2,612 Reduced 0.27%	965,192 $26.8 Million
Q3 2023 Nov 02, 2023	BUY	$27.17 - $31.97 $3.16 Million - $3.72 Million	116,474 Added 13.68%	967,804 $27.1 Million
Q2 2023 Aug 09, 2023	BUY	$28.34 - $33.63 $1.72 Million - $2.04 Million	60,630 Added 7.67%	851,330 $26.6 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $7.22 Million - $8.28 Million	285,424 Added 56.49%	790,700 $22.3 Million
Q4 2022 Feb 08, 2023	BUY	$21.94 - $26.24 $2.54 Million - $3.03 Million	115,548 Added 29.65%	505,276 $13.2 Million
Q3 2022 Nov 09, 2022	BUY	$22.0 - $31.87 $1.76 Million - $2.55 Million	79,985 Added 25.82%	389,728 $8.7 Million
Q2 2022 Aug 10, 2022	BUY	$26.4 - $30.54 $72,204 - $83,526	2,735 Added 0.89%	309,743 $9.23 Million
Q1 2022 May 04, 2022	BUY	$23.07 - $27.99 $46,739 - $56,707	2,026 Added 0.66%	307,008 $8.08 Million
Q4 2021 Feb 10, 2022	BUY	$21.47 - $32.08 $1.14 Million - $1.7 Million	52,967 Added 21.02%	304,982 $7.09 Million
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $5.89 Million - $8.1 Million	252,015 New	252,015 $7.77 Million
Q2 2021 Aug 13, 2021	SELL	$18.78 - $25.15 $6.66 Million - $8.92 Million	-354,615 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $1.02 Million - $1.31 Million	-56,251 Reduced 13.69%	354,615 $6.62 Million
Q4 2020 Feb 02, 2021	BUY	$15.39 - $22.1 $707,755 - $1.02 Million	45,988 Added 12.6%	410,866 $8.2 Million
Q3 2020 Nov 05, 2020	BUY	$16.16 - $20.66 $219,582 - $280,728	13,588 Added 3.87%	364,878 $6.05 Million
Q2 2020 Aug 12, 2020	SELL	$13.31 - $19.41 $11,140 - $16,246	-837 Reduced 0.24%	351,290 $6.82 Million
Q1 2020 May 12, 2020	SELL	$13.06 - $21.24 $232,468 - $378,072	-17,800 Reduced 4.81%	352,127 $5.08 Million
Q4 2019 Jan 27, 2020	BUY	$17.29 - $21.74 $497,191 - $625,155	28,756 Added 8.43%	369,927 $7.55 Million
Q3 2019 Oct 31, 2019	BUY	$19.51 - $24.28 $2.71 Million - $3.38 Million	139,071 Added 68.81%	341,171 $6.66 Million
Q2 2019 Aug 15, 2019	SELL	$21.47 - $37.33 $378,838 - $658,687	-17,645 Reduced 8.03%	202,100 $4.56 Million
Q1 2019 May 03, 2019	SELL	$28.4 - $36.49 $427,022 - $548,663	-15,036 Reduced 6.4%	219,745 $8.02 Million
Q4 2018 Feb 08, 2019	SELL	$27.94 - $44.61 $533,989 - $852,586	-19,112 Reduced 7.53%	234,781 $6.93 Million
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $1.41 Million - $1.68 Million	-36,448 Reduced 12.55%	253,893 $10.8 Million
Q2 2018 Aug 15, 2018	SELL	$40.56 - $51.36 $2.59 Million - $3.28 Million	-63,881 Reduced 18.03%	290,341 $12 Million
Q1 2018 May 11, 2018	SELL	$53.61 - $67.26 $1.01 Million - $1.27 Million	-18,924 Reduced 5.07%	354,222 $20.5 Million
Q4 2017 Feb 06, 2018	BUY	$47.69 - $55.39 $6.62 Million - $7.69 Million	138,846 Added 59.26%	373,146 $20.4 Million
Q3 2017 Nov 15, 2017	BUY	$49.16 - $54.45 $11.5 Million - $12.8 Million	234,300	234,300 $11.9 Million

Others Institutions Holding ALKS

# of Institutions

346

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.76B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Alkermes Plc. Transaction History